Beijing SL Pharmaceutical Co., Ltd. (002038.SZ)
CNY 7.26
(0.41%)
CNY 7.26
(0.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 493.57 Million | 389.82 Million | 464.62 Million | 415.83 Million | 665.82 Million | 485.17 Million |
| Net Income | 416.69 Million | 228.34 Million | 421.32 Million | 361.45 Million | 479.49 Million | 563.39 Million |
| Depreciation & Amortization | 145.67 Million | 113.87 Million | 99.8 Million | 89.49 Million | 76.59 Million | 55.79 Million |
| Deferred income taxes | 30.46 Million | -6.27 Million | 14.36 Million | 25.56 Million | -7.08 Million | 6.48 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 81.98 Million | 113.74 Million | 129.05 Million | 197.94 Million | 141.65 Million | -141.96 Million |
| Other non-cash items | 28.11 Million | -66.14 Million | -185.55 Million | -233.05 Million | -31.92 Million | 7.94 Million |
| Investing Cash Flow | -378.02 Million | -540.4 Million | -197.82 Million | -842.14 Million | -383.17 Million | -415.66 Million |
| Investments in PPE | -218.35 Million | -163.48 Million | -236.91 Million | -255.94 Million | -272.78 Million | -227.37 Million |
| Acquisitions | 14 Thousand | -3.4 Million | 16.49 Million | 7990.00 | 33.22 Thousand | 227.37 Million |
| Investment purchases | -690 Million | -1.24 Billion | -1.06 Billion | -1.51 Billion | -579.86 Million | -987.63 Million |
| Sales/Maturities of investments | 603.05 Million | 896.09 Million | 1.09 Billion | 964.33 Million | 469.3 Million | 799.34 Million |
| Other Investing Activities | -72.73 Million | -22.2 Million | -8.99 Million | -33.33 Million | 130 Thousand | -227.37 Million |
| Financing Cash Flow | -102.73 Million | -102.73 Million | -103.33 Million | -206.92 Million | -198.95 Million | -342.45 Million |
| Debt repayment | - | - | -11 Million | -5.59 Million | -3.92 Million | - |
| Dividends payments | -102.73 Million | -102.73 Million | -102.73 Million | -205.47 Million | -547.92 Million | -342.45 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | 10.6 Million | 4.49 Million | 10.53 Million | - |
| Accounts receivables | 19.66 Million | 82.87 Million | 108.64 Million | 198.77 Million | -9.26 Million | -160.51 Million |
| Accounts payables | 66.57 Million | 36.56 Million | 17.54 Million | -22.71 Million | 15.08 Million | -12.36 Million |
| Inventory | -4.25 Million | 584.99 Thousand | -11.49 Million | -3.68 Million | 142.92 Million | 24.42 Million |
| Other working capital | 97.04 Million | -6.27 Million | 14.36 Million | 25.56 Million | -7.08 Million | -166.39 Million |
| Cash at beginning of period | 595.03 Million | 780.41 Million | 616.96 Million | 1.25 Billion | 1.16 Billion | 1.43 Billion |
| Cash at end of period | 683.83 Million | 527.19 Million | 780.41 Million | 616.96 Million | 1.25 Billion | 1.16 Billion |
| Capital Expenditure | -218.35 Million | -163.48 Million | -236.91 Million | -255.94 Million | -272.78 Million | -227.37 Million |
| Effect of forex changes on cash | 32.95 Thousand | 103.47 Thousand | -22.83 Thousand | 81.09 Thousand | 213.54 Thousand | 337.7 Thousand |
| Net cash flow / Change in cash | 88.79 Million | -253.21 Million | 163.45 Million | -633.14 Million | 83.91 Million | -272.6 Million |
| Free Cash Flow | 275.21 Million | 226.33 Million | 227.71 Million | 159.88 Million | 393.04 Million | 257.79 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | -40.54 Million | 70.13 Million | 416.69 Million | 99.12 Million | 403.95 Thousand |
| Depreciation & Amortization | - | 36.67 Million | 36.67 Million | 145.67 Million | 39.57 Million | -66.42 Million |
| Deferred income taxes | - | - | - | 30.46 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 94.15 Million | - | 81.98 Million | 15.41 Million | 78.2 Million |
| Other non-cash items | - | 128.8 Million | 39.91 Million | 28.11 Million | 192.84 Million | 29.35 Million |
| Investing Cash Flow | -63.25 Million | -24.7 Million | -28.09 Million | -378.02 Million | -285.16 Million | -26.94 Million |
| Investments in PPE | -44.08 Million | -54.7 Million | -26.09 Million | -218.35 Million | -97.43 Million | -40.83 Million |
| Acquisitions | - | - | - | 14 Thousand | - | 14 Thousand |
| Investment purchases | -273.04 Million | -20 Million | -2 Million | -690 Million | -580 Million | -14 Thousand |
| Sales/Maturities of investments | 253.87 Million | 72.52 Million | 3.3 Million | 603.05 Million | 465 Million | 13.87 Million |
| Other Investing Activities | - | 52.52 Million | 1.3 Million | -72.73 Million | -72.73 Million | 14 Thousand |
| Financing Cash Flow | - | - | - | -102.73 Million | - | -7.51 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | -102.73 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | 127.75 Million | - | 19.66 Million | 19.66 Million | 55.14 Million |
| Accounts payables | - | - | - | 66.57 Million | - | - |
| Inventory | - | -33.6 Million | - | -4.25 Million | -4.25 Million | 23.06 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 648.88 Million | 643.13 Million | 683.83 Million | 595.03 Million | 735.39 Million | 565.7 Million |
| Cash at end of period | 423.55 Million | 670.98 Million | 643.13 Million | 683.83 Million | 683.83 Million | 572.78 Million |
| Capital Expenditure | -44.08 Million | -54.7 Million | -26.09 Million | -218.35 Million | -97.43 Million | -40.83 Million |
| Effect of forex changes on cash | -1.56 | 0.94 | -2.83 | 32.95 Thousand | 31.08 Thousand | -7.02 |
| Net cash flow / Change in cash | -225.32 Million | 27.84 Million | -40.69 Million | 88.79 Million | -51.56 Million | 7.07 Million |
| Free Cash Flow | -44.08 Million | -3.11 Million | 83.95 Million | 275.21 Million | 154.95 Million | 705.46 Thousand |
BTCY
NEOEN
ASGR
000607
0874
BNB